Iodine quantification with dual-energy CT: Phantom study and preliminary experience with renal masses

American Journal of Roentgenology

Volumn 196, Issue 6, 2011, Pages

  Chandarana, Hersh ^a   Megibow, Alec J ^a   Cohen, Benjamin A ^a   Srinivasan, Ramya ^a   Kim, Danny ^a   Leidecker, Christianne ^b   Macari, Michael ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b SIEMENS CORPORATE RESEARCH   (United States)

Author keywords

Dual energy CT; Iodine quantification; Renal lesion; Renal mass

Indexed keywords

IODINE;

ADULT; AGED; AORTA; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DUAL ENERGY COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEMORRHAGIC CYST; HUMAN; IMAGE ENHANCEMENT; IMAGE PROCESSING; KIDNEY CYST; KIDNEY HEMORRHAGE; KIDNEY TUMOR; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PHANTOM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IODINE; IOHEXOL; KIDNEY DISEASES; MALE; MIDDLE AGED; PHANTOMS, IMAGING; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RADIOGRAPHY, DUAL-ENERGY SCANNED PROJECTION; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79960551830     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.5541     Document Type: Article

References (36)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58:71-96
2. Tsui KH, Shvarts O, Smith RB, et al. Renal cell carcinoma: prognostic significance of incidentally detected tumors. J Urol 2000; 163:426-430 (Pubitemid 30060485)
3. Sheth S, Scatarige JC, Horton KM, et al. Current concepts in the diagnosis and management of renal cell carcinoma: role of multidetector CT and three-dimensional CT. RadioGraphics 2001; 21(spec no):S237-S254
4. Kopka L, Fischer U, Zoeller G, et al. Dual-phase helical CT of the kidney: value of the corticomedullary and nephrographic phase for evaluation of renal lesions and preoperative staging of renal cell carcinoma. AJR 1997; 169:1573-1578 (Pubitemid 127469782)
5. Israel GM, Bosniak MA. How I do it: evaluating renal masses. Radiology 2005; 236:441-450 (Pubitemid 41023424)
6. Israel GM, Bosniak MA. Pitfalls in renal mass evaluation and how to avoid them. RadioGraphics 2008; 28:1325-1338
7. Birnbaum BA, Hindman N, Lee J, et al. Multidetector row CT attenuation measurements: assessment of intra- and interscanner variability with an anthropomorphic body CT phantom. Radiology 2007; 242:109-119 (Pubitemid 44956015)
8. Birnbaum BA, Hindman N, Lee J, et al. Renal cyst pseudoenhancement: influence of multidetector CT reconstruction algorithm and scanner type in phantom model. Radiology 2007; 244:767-775 (Pubitemid 47292087)
9. Graser A, Johnson TR, Chandarana H, et al. Dual energy CT: preliminary observations and potential clinical applications in the abdomen. Eur Radiol 2009; 19:13-23
10. Chandarana H, Godoy MC, Vlahos I, et al. Abdominal aorta: evaluation with dual-source dualenergy multidetector CT after endovascular repair of aneurysms - initial observations. Radiology 2008; 249:692-700
11. Graser A, Johnson TR, Hecht EM, et al. Dual-energy CT in patients suspected of having renal masses: can virtual nonenhanced images replace true nonenhanced images? Radiology 2009; 252:433-440
12. Graser A, Becker CR, Staehler M, et al. Single-phase dual-energy CT allows for characterization of renal masses as benign or malignant. Invest Radiol 2010; 45:399-405
13. Johnson TR, Krauss B, Sedlmair M, et al. Material differentiation by dual energy CT: initial experience. Eur Radiol 2007; 17:1510-1517 (Pubitemid 46767599)
14. Petersilka M, Bruder H, Krauss B, et al. Technical principles of dual source CT. Eur J Radiol 2008; 68:362-368
15. Chung EP, Herts BR, Linnell G, et al. Analysis of changes in attenuation of proven renal cysts on different scanning phases of triphasic MDCT. AJR 2004; 182:405-410 (Pubitemid 38116583)
16. Fletcher JG, Takahashi N, Hartman R, et al. Dual-energy and dual-source CT: is there a role in the abdomen and pelvis? Radiol Clin North Am 2009; 47:41-57
17. Vrtiska TJ, Takahashi N, Fletcher JG, Hartman RP, Yu L, Kawashima A. Genitourinary application of dual-energy CT. AJR 2010; 194:1434-1442
18. Pontana F, Faivre JB, Remy-Jardin M, et al. Lung perfusion with dual-energy multidetector-row CT (MDCT): feasibility for the evaluation of acute pulmonary embolism in 117 consecutive patients. Acad Radiol 2008; 15:1494-1504
19. Zhang Y, Zhang ZH, Jin ZY, et al. Radiological features of dual-energy CT lung perfusion imaging in patients with acute pulmonary embolism: comparison with CT pulmonary angiography. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2009; 31:166-170
20. Thieme SF, Becker CR, Hacker M, et al. Dual energy CT for the assessment of lung perfusion: correlation to scintigraphy. Eur J Radiol 2008; 68:369-374
21. Brown CL, Hartman RP, Dzyubak OP, et al. Dual-energy CT iodine overlay technique for characterization of renal masses as cyst or solid: a phantom feasibility study. Eur Radiol 2009; 19:1289-1295
22. Leschka S, Stolzmann P, Baumuller S, et al. Performance of dual-energy CT with tin filter technology for the discrimination of renal cysts and enhancing masses. Acad Radiol 2010; 17:526-534
23. Karlo C, Lauber A, Götti RP, et. al. Dual-energy CT with tin filter technology for the discrimination of renal lesion proxies containing blood, protein, and contrast-agent: an experimental phantom study. Eur Radiol 2011; 21:385-392 [Epub 2010 Aug 15]
24. Platt JF, Reige KA, Ellis JH. Aortic enhancement during abdominal CT angiography: correlation with test injections, flow rates, and patient demographics. AJR 1999; 172:53-56 (Pubitemid 29028429)
25. Bae KT, Heiken JP, Brink JA. Aortic and hepatic contrast medium enhancement at CT. Part II. Effect of reduced cardiac output in a porcine model. Radiology 1998; 207:657-662
26. Bae KT, Heiken JP, Brink JA. Aortic and hepatic peak enhancement at CT: effect of contrast medium injection rate-pharmacokinetic analysis and experimental porcine model. Radiology 1998; 206:455-464 (Pubitemid 28112962)
27. Herts BR, Coll DM, Novick AC, et al. Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys. AJR 2002; 178:367-372 (Pubitemid 34098041)
28. Ruppert-Kohlmayr AJ, Uggowitzer M, Ruppert G. Differentiation of renal clear cell carcinoma and renal papillary carcinoma using quantitative CT enhancement parameters. AJR 2004; 183:1387-1391 (Pubitemid 44210606)
29. Zhang J, Lefkowitz RA, Ishill NM, et al. Solid renal cortical tumors: differentiation with CT. Radiology 2007; 244:494-504 (Pubitemid 47080882)
30. Kim JK, Kim TK, Ahn HJ, et al. Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR 2002; 178:1499-1506 (Pubitemid 34547840)
31. Cuenod CA, Fournier L, Balvay D, Guinebretière JM. Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment. Abdom Imaging 2006; 31:188-193
32. Choi H. Critical issues in response evaluation on computed tomography: lessons from the gastrointestinal stromal tumor model. Curr Oncol Rep 2005; 7:307-311 (Pubitemid 41149677)
33. Smith AD, Shah SN, Rini BI, Lieber ML, Remer EM. Morphology, attenuation, size, and structure (MASS) criteria: assessing response and predicting clinical outcome in metastatic renal cell carcinoma on antiangiogenic targeted therapy. AJR 2010; 194:1470-1478
34. Hillman GG, Singh-Gupta V, Zhang H, et al. Dynamic contrast-enhanced magnetic resonance imaging of vascular changes induced by sunitinib in papillary renal cell carcinoma xenograft tumors. Neoplasia 2009; 11:910-920
35. Lassau N, Chebil M, Chami L, Bidault S, Girard E, Roche A. Dynamic contrast-enhanced ultrasonography (DCE-US): a new tool for the early evaluation of antiangiogenic treatment. Target Oncol 2010; 5:53-58
36. 11C-acetate PET for early prediction of sunitinib response in metastatic renal cell carcinoma. Tumori 2009; 95:382-384